Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Systematische random biopten verbeteren vroege diagnose erfelijke diffuse maagkanker
feb 2023 | Endoscopie, Maag-darm-leveroncologie